1. Introduction {#sec0005}
===============

Primary sarcomas of the gallbladder (GB) are a rare disease that were first described by Griffon and Segall in 1897 \[[@bib0005]\]. Women are more often affected than men. In the majority of published cases, primary sarcomas of the GB appear between the 6th and 7th decade of life \[[@bib0010],[@bib0015]\]. Leiomyosarcomas (LMS), as described in the case report at hand, are considered a major subgroup \[[@bib0010], [@bib0015], [@bib0020]\].

The work has been reported in accordance with the SCARE criteria \[[@bib0025]\].

2. Presentation of case {#sec0010}
=======================

A 62-year-old female was referred to our hospital due to intermittent right upper quadrant and epigastric pain for 7 days in 2015. Her medical history consisted of hypothyroidism and pyelonephritis. Her surgical history included an appendectomy. During the clinical examination a positive murphy sign was found. The laboratory tests demonstrated an elevated bilirubin, y-glutamyl transferase, alkaline phosphatase, and lipase. Additionally, the inflammatory markers were elevated. The patient underwent an abdominal ultrasound. An inflamed GB with multiple gallstones was detected. Moreover, a 45 mm mass arising from the neck of GB was found ([Fig. 1](#fig0005){ref-type="fig"}). Therefore, we conducted an upper endoscopy. No choledocholithiasis was detected. The 45 mm sized tumours had a space-occupying effect on the stomach. The endosonography, MRI and abdominal CT scan did not show distant metastases ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}). The mass of unknown dignity showed a contrast agent uptake, but no signs of an infiltrative growth pattern. After a multidisciplinary discussion within our tumor board, the decision was made to remove the mass, with the suspicion of finding a malignant entity. Intraoperatively, neither liver metastases nor the infiltration of the omental fat were revealed. We resected the inflamed gallbladder, as well as the fossa. Additionally, we performed a lymphadenectomy of the hepatoduodenal ligament. The frozen section analysis of the excision margins of the cystic duct did not show any malignant cells.Fig. 1A 4,5 cm mass of the neck of the GB can be seen (marked with a star) on the left side. A gallstone is located next to the tumor. The MRI reveals a tumor marked by the black arrow.Fig. 1Fig. 2Case report timeline.Fig. 2

2.1. Pathological findings {#sec0015}
--------------------------

The histopathological examination diagnosed an R0 resected 40 mm smooth bounded spindle-shaped epithelioid tumor in a chronic inflamed GB. The liver tissue and lymph nodes did not contain malignant cells ([Fig. 3](#fig0015){ref-type="fig"}, Picture I).Fig. 3Immunohistochemical detection of DOG1, Calponin and Caldesmon.Fig. 3

2.2. Immunohistochemical findings {#sec0020}
---------------------------------

The immunohistochemical examination revealed the expression of DOG1, Calponin and Caldesmon ([Fig. 3](#fig0015){ref-type="fig"}, Picture II--III).

The postoperative course was uneventful. We discharged our patient 12 days after surgery.

As a follow-up approach, we decided to perform a CT scan every 6 months. No tumor recurrence or metastases were detected up to this day. Our patient remains alive and in good health.

3. Discussion {#sec0025}
=============

Primary sarcomas of the GB are a rare malignancy. The majority of these sarcomas are leiomyosarcomas. An incidence is estimated as 1.4 per 1000 malignancies of the GB \[[@bib0030],[@bib0035]\].

To reveal further knowledge on epidemiology, therapy and outcome of patients with LMS of the GB, we reviewed the literature using the search terms "Sarcoma," "Leiomyosarcoma," and "Gallbladder", with Google Scholar and PubMed. The search yielded 30 relevant publications \[[@bib0005],[@bib0010],[@bib0020],[@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100], [@bib0105], [@bib0110], [@bib0115], [@bib0120], [@bib0125], [@bib0130]\]. We excluded publications without available abstracts or insufficient information regarding the patient's medical history. 10 publications were excluded ([Table 1](#tbl0005){ref-type="table"}). The articles' publication dates range from 1982 to 2018. Among the 20 publications, the medical history of 24 patients who suffered from a LMS of the GB was reported. In 23 cases, the LMS occurred primarily in the GB. 18 patients were female, and 6 patients were male with an average age of 65.95 years. The diameter of the mass ranged between 2 and 8 cm. Egorov et al. published a case of a large LMS that weighed 1500 g \[[@bib0110]\]. In 4 cases, the LMS infiltrated the surrounding organs.Table 1Publications on Leiomyosarcoma (LMS) of the gallbladder.Table 1AuthorYear of publicationGenderAgeLocationSize *cm*Pathological findingsTreatmentOutcome*YearsSecondary/Primary LMSmonth of survival after surgery*Guo et al.2016female41NR5 × 4,2 × 2,5SecondaryCCE\>30Savlania et al.2012female50Fundus and Corpus5 × 4 × 3PrimaryCCE, Resection of liver segment IVb + V12Im et al.2014male82Corpus5.5PrimaryCCE, hepatic wedge resection via laparotomyNRPark et al.2012male54NR7 × 5,5PrimaryCCE, Resection of liver segment IVb + V, omentectomy, small bowel segmental resection, lymphadenectomy *ligamentum hepatoduodenale*3Sherine et al.2010female50NRNRPrimaryCCENRAl-Daraji et al.2009female36NR3,0PrimaryNR20female81NR4.4PrimaryNR5Garcia et al.2009male79NRNRPrimaryCT-guided percutaneous drainage due to abscess and cholecystitis\< 1, DODfemale81NRNRPrimaryExplorative Laparotomie with gastrojejunostomy and ileotransversostomy and biopsy of GB\< 1, DODHusain et al.2009female82NR4PrimaryChemotherapyNRIeda et al.2006female78Invasion of liver, duodenumNRsPrimaryCCE, distal gastrectomy, hepatectomy of the IVa, V, partial resection of transverse colon and duodenumNRPerez-Montiel et al.2004female32Fundus2 × 2 × 1,5PrimaryCCE\> 24Katagiri et al.2003male66NRNRPrimaryCCE, lymphadenectomyNRIshii et al.2002female80NRNRPrimaryCCE\> 21Danikas et al.2001female51Fundus with liver extensionNRPrimaryCCE, liver biopsy\< 1; DODTaniai et al.1998female67NRNRPrimaryCCE, wedge resection of the liver\> 12Fotiadis et al.1990female64NR7 × 5 × 2PrimaryCCE6; DODEgorov et al.1989female73NRNRPrimaryNRNR; DODTarasov et al.1987female55NRNRPrimaryNRNRAsamura et al.1986female72Liver and bowel infiltrationNRPrimaryCCE wedge resection of the liver, resection of transverse colon and affected parietal peritoneum\<2; DODCoelho et. al.1984female69NR6,5 × 6,2PrimaryLaparotomy with CCENRWillen et al.1982female91Fundus2 cmPrimaryNRPMDmale77NR8 cmPrimaryCCENRmale72NR, metastasis to liver and lungNRPrimaryNRNR[^1]

The diagnosis of a LMS is established in accordance with the World Health Organization classification for soft tissue tumors \[[@bib0015]\]. This tumor entity consists of cells showing distinct smooth muscle features. Macroscopically, the LMS forms a white and grey coloured fleshy mass. The microscopic pattern typically consists of intersecting, sharply marginated groups of spindle cells. Usually, the LMS is immunohistochemically positive for desmin, h-caldesmon, and SMA. Immunostainings may be focally positive for CD34, epithelial membrane antigen (EMA), keratin, and S100 \[[@bib0015],[@bib0050]\].

Patients who suffered from a LMS of the GB often present with abdominal pain, fever, jaundice, and weight loss \[[@bib0030]\]. In certain cases, as the one presented here, an acute or chronic cholecystitis, accompanied by cholelithiasis led to the diagnosis of a GB tumor. Predisposing factors regarding the pathogenesis of the LMS may be gallstones and chronic inflammation of the GB \[[@bib0030]\]. Our review revealed that the majority \[[@bib0065],[@bib0120]\] of patients were referred to the hospital suffering from gallstones with an acute or chronic inflammation of the GB \[[@bib0005],[@bib0010],[@bib0035],[@bib0055],[@bib0060],[@bib0070],[@bib0075],[@bib0085],[@bib0095],[@bib0100],[@bib0115]\].

As a diagnostic approach, an ultrasound examination, a CT scan, as well as a PET-CT scan are recommended. The LMS may occur as a polypoid mass protruding into the lumen with an irregularly thickened wall. Nevertheless, the lack of specific radiological features makes the differentiation from an adenocarcinoma challenging \[[@bib0030]\].

Similar radiological, histological and immunohistochemical features make the adenocarcinoma, the rhabdomyosarcoma, the liposarcoma, the Kaposi sarcoma, and the angiosarcoma an important differential diagnosis to consider \[[@bib0060],[@bib0065]\].

The therapy depends on the tumor extension. In a non-metastatic stage, the cholecystectomy combined with a wedge resection of the surrounding liver tissue, as well as a lymphadenectomy of the hepatoduodenal ligament seems to be a sufficient surgical approach \[[@bib0030],[@bib0045],[@bib0050],[@bib0075],[@bib0095],[@bib0125]\]. Contrarily, Guo et al. and Perez-Montiel et al. treated a LMS of the GB by performing a solely cholecystectomy. Their patients survival rate was about 2 years \[[@bib0040],[@bib0070]\]. Our review revealed that an extensive surgery was performed in cases of a local tumor invasion \[[@bib0005],[@bib0050],[@bib0065]\]. There is not sufficient evidence in the literature regarding the effectiveness of adjuvant chemo- or radiation therapy. However, some authors reported that chemotherapy with doxorubicin, mitomycin C may improve the long term survival following surgery \[[@bib0005],[@bib0085],[@bib0130]\].

The LMS of the GB has a very poor prognosis, particularly in a metastatic stage \[[@bib0005],[@bib0085]\]. By removing the LMS in an early tumor stage, a long term survival for several years, as shown in our case report, has been described \[[@bib0040],[@bib0070]\].

4. Conclusion {#sec0030}
=============

Particularly when diagnosing a tumor of the GB in elderly women, a leiomyosarcoma should be taken under consideration.

In a non-metastatic stage, the cholecystectomy with a wedge resection of the surrounding liver tissue, as well as a lymphadenectomy of the hepatoduodenal ligament is described as a sufficient surgical approach.
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